Anaerobic protozoa and obligate anaerobic bacteria

Anaerobic protozoa and obligate anaerobic bacteria are a diverse group of microorganisms that function in environments with low or no oxygen. This group includes significant human pathogens such as the protozoans Giardia lamblia and Entamoeba histolytica, as well as bacteria like Clostridium and Bacteroides species (NIH, 2022). These organisms are responsible for a variety of clinical conditions, including gastrointestinal infections, reproductive tract infections, and deep-seated abscesses. The primary therapeutic approach involves drugs like nitroimidazoles, which exploit the unique anaerobic metabolic pathways of these cells (StatPearls, 2023). Within the organism, these drugs are reduced by electron transport proteins such as ferredoxin, which are part of the pyruvate:ferredoxin oxidoreductase (PFOR) system (PubMed, 2019). This reduction process generates highly reactive nitro radical anions that interact with the pathogen's DNA. The resulting DNA strand breakage and inhibition of nucleic acid synthesis lead to rapid cell death. Because these metabolic pathways are absent in aerobic human cells, these drugs exhibit selective toxicity toward the anaerobic pathogens. Monitoring for these infections often involves specialized culture techniques or molecular assays to identify the specific anaerobic species involved.

Other names

Anaerobic microorganismsAnaerobic pathogensObligate anaerobesAnaerobic bacteria and protozoa

Drugs targeting these organisms, specifically nitroimidazoles, act as prodrugs that enter the cell via passive diffusion. In the low-redox environment of the anaerobe, the drug is reduced by electron transport proteins like ferredoxin. This process generates short-lived, highly reactive nitro radical anions and other cytotoxic intermediates that cause DNA strand breakage and inhibit nucleic acid synthesis, leading to cell death (StatPearls, 2023).